BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
AS - Asia 973
NA - Nord America 450
EU - Europa 268
SA - Sud America 14
AF - Africa 6
OC - Oceania 3
Totale 1.714
Nazione #
SG - Singapore 641
US - Stati Uniti d'America 438
CN - Cina 178
HK - Hong Kong 112
GB - Regno Unito 85
IT - Italia 77
DE - Germania 28
NL - Olanda 24
IN - India 19
CA - Canada 12
FR - Francia 11
UA - Ucraina 8
BR - Brasile 7
JP - Giappone 7
CZ - Repubblica Ceca 6
ES - Italia 6
FI - Finlandia 6
TR - Turchia 5
AR - Argentina 4
IE - Irlanda 4
ZA - Sudafrica 4
AU - Australia 3
IL - Israele 3
PK - Pakistan 3
BG - Bulgaria 2
CO - Colombia 2
EE - Estonia 2
MA - Marocco 2
PL - Polonia 2
SA - Arabia Saudita 2
CH - Svizzera 1
CL - Cile 1
HU - Ungheria 1
ID - Indonesia 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 1.714
Città #
Singapore 192
Ashburn 127
Hong Kong 111
Boardman 107
Hefei 98
London 80
Shanghai 59
Council Bluffs 44
Amsterdam 20
Rome 20
Pune 14
San Francisco 14
Bari 13
Washington 13
Toronto 11
Santa Clara 10
Seattle 8
West Jordan 8
Jaguariúna 7
Los Angeles 7
Brno 6
Munich 5
Dublin 4
Helsinki 4
Noicattaro 4
State College 4
Tokyo 4
Ankara 3
Tel Aviv 3
Anantapur 2
Beijing 2
Brest 2
Collazzone 2
Florencio Varela 2
Herne Bay 2
Jinan 2
L'aquila 2
Madrid 2
Makkah 2
Milan 2
Naples 2
Newark 2
Reus 2
Secaucus 2
Sofia 2
Sydney 2
Takatsuki Shi 2
Warsaw 2
Aioicho 1
Bangkok 1
Belgrade 1
Bogotá 1
Boydton 1
Buenos Aires 1
Buffalo 1
Central 1
Charlotte 1
Chennai 1
Chicago 1
Chisinau 1
Danvers 1
Faisalabad 1
Guangzhou 1
Hanover 1
Huizhou 1
Hyderabad 1
Islamabad 1
Karachi 1
Kunming 1
Lecce 1
L’Aquila 1
Markham 1
Melbourne 1
North Bergen 1
Nuremberg 1
Oradea 1
Pamplona 1
Paris 1
Parma 1
Pontonx-sur-l'Adour 1
Rabat 1
Redmond 1
Riga 1
Santiago de Cali 1
Shenzhen 1
Shijiazhuang 1
Siena 1
Suzhou 1
Tangier 1
Tianjin 1
Turku 1
Xi'an 1
Totale 1.082
Nome #
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 67
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 55
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 43
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 41
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 41
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 35
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 34
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 32
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 31
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 30
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 30
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 29
Cardiovascular disease in primary sjögren’s syndrome 29
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 29
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 29
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 28
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 26
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 26
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 25
Vitamin D and systemic lupus erythematosus - The hype and the hope 25
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 25
Cytokine storm syndrome in severe COVID-19 25
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 24
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 24
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 23
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 22
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 21
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 21
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 20
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 20
Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature 19
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 19
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 18
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 18
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 18
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 18
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 17
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 17
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 17
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 17
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 17
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 17
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 16
Interstitial lung disease in systemic sclerosis: current and future treatment. 16
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 16
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 16
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 15
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis 15
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 15
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 15
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 15
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 15
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 14
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm 14
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 14
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 14
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 14
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 14
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 14
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 13
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 13
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 13
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 13
Endothelial-to-mesenchymal transition in systemic sclerosis 13
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al 12
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 12
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 12
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 12
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 12
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 12
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 12
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 12
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 12
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 12
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome 12
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 11
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 11
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 11
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 11
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 11
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 11
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 11
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction 11
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 10
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 10
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 10
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases 9
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 9
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 9
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 9
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 9
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 8
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome 7
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 7
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 6
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 5
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist? 4
Totale 1.771
Categoria #
all - tutte 26.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 0 2 0 0 0 0 0 18 4 5 82
2022/202398 1 2 2 4 15 1 2 8 3 5 54 1
2023/2024339 16 35 15 40 40 139 7 10 3 13 13 8
2024/20251.223 48 44 117 29 30 72 71 32 252 252 276 0
Totale 1.771